Skip to content
Back to blog
Creyos Is Now a Qualified Solution on Mayo Clinic Platform
Company

Creyos Is Now a Qualified Solution on Mayo Clinic Platform

Published: November 17, 2026 | 2 min read

Written by: Marina White, Senior Healthcare Writer

Table Of Contents

Creyos is proud to share that it is now a qualified solution on Mayo Clinic Platform. Creyos is a digital cognitive and behavioral health assessment platform that supports clinicians in identifying, evaluating, and monitoring conditions such as mild cognitive impairment (MCI), dementia, depression, and anxiety, in clinic or remotely.

About Mayo Clinic Platform qualification

Mayo Clinic Platform supports digital health solution developers with the infrastructure and ecosystem needed to bring digital solutions into real-world clinical and administrative workflows. The qualification program evaluates each solution for intended use, proposed value, and clinical and algorithmic performance, providing transparency and credibility and enabling the adoption of transformative health technologies.

Creyos is qualified for September 2026 to September 2027 and will submit for requalification annually. As a qualified solution, Creyos is included in the Mayo Clinic Platform Solutions Catalog, which brings evaluated digital tools to health systems across the Mayo Clinic Platform network.

What Mayo Clinic Platform reviewed

Creyos documented the platform’s intended use, users, settings, and limitations, and submitted six performance claims about its cognitive tasks. The supporting evidence spoke to:

  • What the tasks measure: distinct areas of cognition, such as memory, reasoning, and verbal ability, each linked to different brain regions.
  • Sensitivity to clinical conditions: differences in task performance in people at risk for neurological conditions, including Alzheimer’s and Parkinson’s disease.
  • Agreement with traditional testing: how Creyos results relate to in-person neuropsychological assessment and common screening tools, in less time.
  • Dementia screening: a two-step protocol that flags possible cognitive impairment and follows up with a fuller assessment.
  • Monitoring over time: negligible practice effects, so patients can be reassessed as care continues.
  • Ease of use: reliable completion by children, older adults, and clinical populations, including remotely and without supervision.

The research behind the claims

The Creyos tasks were built by neuroscientist Prof. Adrian Owen, PhD, OBE, FRS, and are grounded in three decades of cognitive neuroscience research. The 12 online cognitive tasks measure memory, attention, reasoning, executive function, and processing speed, and are scored against a normative database of more than 85,000 participants. They have been used in more than 400 peer-reviewed studies.

What this means for cognitive care

Cognitive impairment often goes undetected in routine care, where brief screening tools can miss early changes and specialist evaluation can be hard to access. Creyos brings objective, standardized cognitive assessment to frontline clinicians, helping organizations identify at-risk patients earlier, support more informed referral decisions, improve documentation, and expand access to cognitive care, including in rural and underserved communities.

See Creyos in action

Learn how Creyos helps your team measure and monitor cognitive health objectively, in clinic or remotely. 
How we keep this article accurate
We review our content regularly to ensure it is up to date.
Share
 
Published
November 17, 2026
Written by
Marina White, PhD
Senior Healthcare Writer at Creyos

Join thousands of healthcare professionals who receive a monthly update on the latest research and news in brain health.